RA CAPITAL MANAGEMENT, LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is a 10% Owner in LIPID SCIENCES INC/ ($LIPD) and a Director in KalVista Pharmaceuticals, Inc. ($CBYL) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Ra Pharmaceuticals, Inc. ($RARX) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and a in G1 Therapeutics, Inc. ($GTHX) and a 10% Owner in Synthorx, Inc. ($THOR) and a 10% Owner in scPharmaceuticals Inc. ($SCPH) and a Director in Wave Life Sciences Ltd. ($WVE) and a in ARVINAS INC. ($ARVN) and a Director in Eidos Therapeutics, Inc. ($EIDX).

Over the past year RA CAPITAL MANAGEMENT, LLC has been an insider in 7 companies. The total value of shares held by RA CAPITAL MANAGEMENT, LLC in these companies amounts to $312,589,306.

RA CAPITAL MANAGEMENT, LLC 10% Owner
Aclaris Therapeutics, Inc.
ARVINAS, INC.
10% Owner, Director
Dicerna Pharmaceuticals Inc
Director
Eidos Therapeutics, Inc.
G1 Therapeutics, Inc.
Director
Kala Pharmaceuticals, Inc.
Director
KalVista Pharmaceuticals, Inc.
10% Owner
LIPID SCIENCES INC/
Director
Ra Pharmaceuticals, Inc.
10% Owner
scPharmaceuticals Inc.
10% Owner
Synthorx, Inc.
Director
Wave Life Sciences Ltd.
$ 312589306 The total value of shares held by RA CAPITAL MANAGEMENT, LLC
Insider Rank

RA CAPITAL MANAGEMENT, LLC ranks 253 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 111 HUNTINGTON AVENUE, SUITE 610 BOSTON 02199 MA

Companies in which RA CAPITAL MANAGEMENT, LLC is an Insider

Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,607,719 shares
Current Value: $65,844,905
Latest Transaction: Sep 19 2016
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 5x
Shares Bought: 0
Shares Sold: 525,550
Share Difference: -525,550
Value Difference: +$12,713,502

ARVINAS, INC.

Trading Symbol: ARVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,847,002 shares
Latest Transaction: Oct 03 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 3,138,412
Shares Sold: 0
Share Difference: +3,138,412
Value Difference: -$16,000,000

Dicerna Pharmaceuticals Inc

Trading Symbol: DRNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner, Director
Holdings: 5,074,013 shares
Current Value: $13,090,954
Latest Transaction: Dec 20 2017
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 2,645,442
Shares Sold: 0
Share Difference: +2,645,442
Value Difference: $0

Eidos Therapeutics, Inc.

Trading Symbol: EIDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,103,847 shares
Latest Transaction: Jun 22 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 4,325,342
Shares Sold: 0
Share Difference: +4,325,342
Value Difference: -$36,000,016

G1 Therapeutics, Inc.

Trading Symbol: GTHX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,723,304 shares
Latest Transaction: May 24 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 2,684,244
Shares Sold: 0
Share Difference: +2,684,244
Value Difference: -$6,000,000

Kala Pharmaceuticals, Inc.

Trading Symbol: KALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 4,537,478 shares
Latest Transaction: Oct 05 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 6,961,720
Shares Sold: 0
Share Difference: +6,961,720
Value Difference: -$47,999,987

KalVista Pharmaceuticals, Inc.

Trading Symbol: KALV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,441,070 shares
Latest Transaction: Oct 16 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,441,070
Shares Sold: 0
Share Difference: +1,441,070
Value Difference: -$7,225,000

LIPID SCIENCES INC/

Trading Symbol: LIPD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,713,962 shares
Latest Transaction: Mar 28 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 4,858,260 shares
Current Value: $88,274,584
Latest Transaction: Dec 14 2018
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 4,858,260
Shares Sold: 0
Share Difference: +4,858,260
Value Difference: -$32,700,000

scPharmaceuticals Inc.

Trading Symbol: SCPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,247,005 shares
Latest Transaction: Apr 15 2019

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 389,862
Shares Sold: 0
Share Difference: +389,862
Value Difference: -$1,052,627

Synthorx, Inc.

Trading Symbol: THOR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 1,525,235 shares
Latest Transaction: Dec 13 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 9,724,598
Shares Sold: 0
Share Difference: +9,724,598
Value Difference: -$50,000,004

Wave Life Sciences Ltd.

Trading Symbol: WVE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 7,775,207 shares
Current Value: $224,314,722
Latest Transaction: Jan 28 2019
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 686,556
Shares Sold: 0
Share Difference: +686,556
Value Difference: -$19,881,554

Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC

Sentiment: All, ACRS, ARVN, DRNA, EIDX, GTHX, KALA, KALV, LIPD, RARX, SCPH, THOR, WVE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 15 2019SCPHscPharmaceuticals ...RA CAPITAL MANAGEMENT, LLC10% OwnerBuyP2.70389,8621,052,6273,247,0052.9 M to 3.2 M (+13.65 %)
Jan 28 2019WVEWave Life Sciences ...RA CAPITAL MANAGEMENT, LLCDirectorBuyP38.00263,15810,000,0047,775,2077.5 M to 7.8 M (+3.50 %)
Dec 14 2018RARXRa Pharmaceuticals ...RA CAPITAL MANAGEMENT, LLCDirectorBuyP15.501,006,45215,600,0064,858,2603.9 M to 4.9 M (+26.13 %)
Dec 13 2018THORSynthorx, Inc.RA CAPITAL MANAGEMENT, LLC10% OwnerOption ExerciseC0.005,854,43900
Dec 13 2018THORSynthorx, Inc.RA CAPITAL MANAGEMENT, LLC10% OwnerOption ExerciseC0.002,443,79400
Dec 13 2018THORSynthorx, Inc.RA CAPITAL MANAGEMENT, LLC10% OwnerBuyP11.004,545,45550,000,0059,724,5985.2 M to 9.7 M (+87.76 %)
Dec 13 2018THORSynthorx, Inc.RA CAPITAL MANAGEMENT, LLC10% OwnerBuyC0.003,653,90805,179,1431.5 M to 5.2 M (+239.56 %)

View all RA CAPITAL MANAGEMENT, LLC insider transactions.